Innovative design eases therapy compliance and reduces burden on DME and patients
Seattle, Washington –Philips Respironics, a business of Royal Philips (NYSE: PHG, AEX: PHIA), today announced the availability of the Amara View CPAP mask, a minimal contact, full face mask designed with the widest field of vision of leading full face masks. With its innovative under the nose design, Amara View reduces the red marks and irritation on the bridge of the nose that many CPAP patients experience. Amara View, along with other Philips sleep-disordered breathing solutions and services will be on display at SLEEP 2015 (booth #601) in Seattle, Washington from June 8 – 10.
Smaller and lighter than traditional full face masks, Amara View covers less of the patient’s face than comparable masks and eliminates the bulky cushion and frame in front of the eyes, allowing the patient to wear glasses, read, watch TV or use a computer or tablet before falling asleep.
“This is the next generation of CPAP masks, designed to ensure the patient’s comfort and ease the journey to CPAP therapy compliance for both the homecare provider and the patient,” said Mark D’Angelo, Sleep Business Leader of Philips. “Amara View enables homecare providers to offer new and existing CPAP patients a product that limits lifestyle interruptions and requires fewer resources during the acclimation process.”
Amara View is the latest addition to The ANSWER, a three phase process designed to respond to the unprecedented challenges facing today’s physicians and DME providers. The ANSWER impacts every touch point of the patient journey from setup, to compliance, through ongoing resupply. The Amara View works together with other Philips sleep therapy systems and resupply services to transform how homecare providers work, supporting their efforts to continue to provide quality care to their patients.
To see how the Amara View works, fits and provides full face mask wearers with more flexibility, watch this video.
 Data on file, Philips Respironics external and internal testing